Health News
2006-01-13
FDA approves
nausea drug for cancer patients
The Food and Drug
Administration on Wednesday approved Merck’s
antinausea medication Emend for use in conjunction
The Food and Drug
Administration on Wednesday approved Merck’s
antinausea medication Emend for use in conjunction
with other antinausea drugs to treat cancer patients
receiving chemotherapy. Emend, made by Merck, was
shown in a study of breast cancer patients to significantly
reduce the chances for nausea and vomiting when added
to a regimen of already-approved antinausea drugs.
Many of the women studied reported a complete lack of
nausea when taking regimens including Emend.
(Advocate.com)
Click here to follow The Advocate on Twitter.
Page 1 of 1